Recent Updates
Recently added Catalysts
MRNA Positive Sentiment

Moderna to Report Fourth Quarter 2025 Financial Results on Friday, February 13, 2026

Key Takeaway: Moderna, Inc. will host a live conference call on February 13, 2026, to discuss its fourth quarter 2025 financial results and provide a corporate update. The call will be accessible via a webcast on the company's website. An archived version of the call will be available for one year post-event.
Price reaction · baseline $47.99 (2026-01-26 close) · hit pre-market · 3 other MRNA headline(s) in the window, move may be shared
day 0 close
-5.3%
day 1
-5.6%
day 3 · peak
-8.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • Moderna is actively engaging with investors through a conference call.
  • The company is providing updates on its financial performance.
  • Moderna continues to lead in mRNA medicine innovation.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+47%
120-day peak, hindsight
Typical move
5.1%
average across 3 past catalysts
Cash runway
~22 mo
Low dilution risk
Lead asset
mRNA-1645-eODGT8
Phase 1 · HIV Infections

Full Press Release Details

CAMBRIDGE, MA /ACCESS Newswire/ January 26, 2026 /Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Friday, February 13, 2026 to report its fourth quarter 2025 financial results, and provide a corporate update.
A live webcast of the call will be available under "Events and Presentations" in the Investors section of the Moderna website.
The archived webcast will be available on Moderna's website approximately two hours after the conference call and will be available for one year following the call.

About Moderna

Moderna is a pioneer and leader in the field of mRNA medicine. Through the advancement of its technology platform, Moderna is reimagining how medicines are made to transform how we treat and prevent diseases. Since its founding, Moderna's mRNA platform has enabled the development of vaccines and therapeutics across infectious diseases, cancer, rare diseases and more.
With a global team and a unique culture, driven by the company's values and mindsets, Moderna's mission is to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X, Facebook, Instagram, YouTube and LinkedIn.

Investors:Lavina TalukdarSenior Vice President & Head of Investor Relations617-209-5834Lavina.Talukdar@modernatx.com

SOURCE:Moderna, Inc.

Frequently Asked Questions

When will Moderna report its Q4 2025 financial results?

Moderna will report its Q4 2025 financial results on February 13, 2026.

How can I access the Moderna conference call?

The conference call can be accessed via a live webcast on Moderna's website.

Will the conference call be available later?

Yes, an archived version of the call will be available for one year after the event.

What is Moderna's focus in medicine?

Moderna focuses on mRNA medicine to transform treatment and prevention of diseases.

Last updated: Jan 27, 2026